CareDx (CDNA) | Stock Overview & Key Data
CareDx Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $99.83 on January 18, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| CareDx CDNA | 1.06B Small-cap | -5.58% | -6.44% | 4.12% | -18.79% | -14.27% | 23.89% | -26.73% | -43.30% |
| Thermo Fisher TMO | 152.45B Large-cap | 3.27% | 2.49% | -4.38% | -23.27% | -19.88% | -20.51% | -22.46% | 12.22% |
| Danaher DHR | 140.51B Large-cap | 1.06% | 0.22% | 10.52% | -16.51% | -13.13% | -15.07% | -13.10% | 24.79% |
| Twist Bioscience TWST | 2.15B Mid-cap | -3.26% | 6.68% | -3.78% | -21.99% | -21.45% | -21.25% | -9.70% | -30.23% |
| Grail GRAL | 1.51B Small-cap | -12.78% | 12.04% | 87.03% | 150.98% | 150.28% | 207.37% | 219.56% | 219.56% |
| Opko Health OPK | 1.01B Small-cap | 1.52% | -2.90% | -12.42% | -11.26% | -7.59% | 7.94% | -51.60% | -66.17% |
Ownership & Short Interest
CareDx Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in CareDx would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, CareDx reached a high of $34.84 (on August 19, 2024) and a low of $14.09 (on May 6, 2025).
Curious about CareDx's size and valuation? Its market capitalization stands at 1.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.92, and the forward P/E (looking ahead) is 32.67.
As for dividends, CareDx isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at CareDx, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO152.45B Healthcare Diagnostics & Research -20.51% -22.46% Danaher
DHR140.51B Healthcare Diagnostics & Research -15.07% -13.10% Twist Bioscience
TWST2.15B Healthcare Diagnostics & Research -21.25% -9.70% Grail
GRAL1.51B Healthcare Diagnostics & Research 207.37% 219.56% Opko Health
OPK1.01B Healthcare Diagnostics & Research 7.94% -51.60% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of CareDx's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.54%, the Debt to Equity ratio from the most recent quarter is 7.98, and its Gross Profit Margin stands at 66.45%.
Looking at CareDx's growth, its revenue over the trailing twelve months (TTM) was $346M. Compared to the same quarter last year (YoY), quarterly revenue grew by 17.50%, and quarterly earnings saw a YoY growth of 17.54%.
Wondering who owns CareDx stock? Company insiders (like executives and directors) hold about 3.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.39%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.